Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients
Objective: Neuroblastoma is one of the common tumors of childhood. The demonstration of new factors such as isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) mutations will be important in the diagnosis and treatment. IDH1 and IDH2 mutations have been found in many types of can...
Saved in:
Main Authors: | Emre LEVENTOGLU, Gurses SAHIN, Sule YESIL, Ceyhun BOZKURT, Nazmiye YUKSEK, Ali FETTAH, Sule TOPRAK, Burcak KURUCU BILGIN, Emre CAPKINOGLU, Nilgun EROGLU, Sibel AKPINAR TEKGUNDUZ, Ayse Ulya ERTEM |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2023-06-01
|
Series: | Medeniyet Medical Journal |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=medeniyet&un=MEDJ-48768 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
by: Zhiyang Huang, et al.
Published: (2025-02-01) -
Deep learning for stage prediction in neuroblastoma using gene expression data
by: Aron Park, et al.
Published: (2019-09-01) -
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
by: Seema Chugh, et al.
Published: (2025-02-01) -
Presentation of disseminated neuroblastoma mimicking Bell’s palsy: a case report
by: Shamaali Gunawardana, et al.
Published: (2025-01-01) -
Predictive role of SLC1A5 in neuroblastoma prognosis and immunotherapy
by: Jian Cheng, et al.
Published: (2025-01-01)